Compare SPWH & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPWH | CVM |
|---|---|---|
| Founded | 1986 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.1M | 41.2M |
| IPO Year | 2014 | 1996 |
| Metric | SPWH | CVM |
|---|---|---|
| Price | $1.18 | $4.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $2.95 | N/A |
| AVG Volume (30 Days) | ★ 350.5K | 57.9K |
| Earning Date | 03-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,197,633,000.00 | $264,033.00 |
| Revenue This Year | $2.62 | N/A |
| Revenue Next Year | $0.41 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 65.45 |
| 52 Week Low | $0.92 | $0.18 |
| 52 Week High | $4.33 | $13.48 |
| Indicator | SPWH | CVM |
|---|---|---|
| Relative Strength Index (RSI) | 34.22 | 48.06 |
| Support Level | $1.16 | $4.65 |
| Resistance Level | $1.35 | $5.18 |
| Average True Range (ATR) | 0.09 | 0.45 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 18.33 | 45.08 |
Sportsman's Warehouse Holdings Inc together with its subsidiaries operates as an outdoor sporting goods retailer. It provides a one-stop shopping experience that equips customers with the right quality, brand name hunting, shooting, fishing, and camping gear to maximize enjoyment of the outdoors. The company offers products in the categories of Camping, Apparel, Fishing, Footwear, Hunting and shooting, and Optics, Electronics, Accessories, and Other products. It provides products such as Backpacks, Jackets, Camp essentials, Hiking boots, GPS devices, ATV accessories and Fishing rods, among others.
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.